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ABSTRACT

ARTICLE HISTORY

Background: Oral microbiota is believed to play important roles in systemic diseases,
including cancer.
Methods: We collected oral samples (tongue, buccal, supragingival, and saliva) and pancrea
tic tissue or intestinal samples from 52 subjects, and characterized 16S rRNA genes using
high-throughput DNA sequencing.
Results: Bray–Curtis plot showed clear separations between bacterial communities in the oral
cavity and those in intestinal and pancreatic tissue samples. PERMANOVA tests indicated that
bacterial communities from buccal samples were similar to supragingival and saliva samples,
and pancreatic duct samples were similar to pancreatic tumor samples, but all other samples
were significantly different from each other. A total of 73 unique Amplicon Sequence Variants
(ASVs) were shared between oral and pancreatic or intestinal samples. Only four ASVs showed
significant concordance, and two specific bacterial species (Gemella morbillorum and
Fusobacterium nucleatum subsp. vincentii) showed consistent presence or absence patterns
between oral and intestinal or pancreatic samples, after adjusting for within-subject correla
tion and disease status. Lastly, microbial co-abundance analyses showed distinct strain-level
cluster patterns among microbiome members in buccal, saliva, duodenum, jejunum, and
pancreatic tumor samples.
Conclusions: Our findings indicate that oral, intestinal, and pancreatic bacterial microbiomes
overlap but exhibit distinct co-abundance patterns in patients with pancreatic cancer and
other gastrointestinal diseases.
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Introduction
The oral cavity is a major gateway to the human
body. It is estimated that the oral cavity collectively
harbors over 700 predominant bacterial species [1].
Oral microbes have been shown to contribute to
a number of oral diseases, including tooth caries,
periodontitis, endodontic infection, alveolar osteitis,
and tonsillitis. It is hypothesized that oral opportu
nistic or pathogenic bacteria can enter into the blood
circulation, passing through the oral mucosal barrier,
potentially resulting in abnormal local and systemic
immune and metabolic responses [2]. Oral micro
biota have been shown to play important roles in
systemic diseases such as cardiovascular diseases, dia
betes mellitus, respiratory diseases, and cancer [3–6].
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Many studies have investigated the relationship
between the oral or gut microbiome and various
cancer risks using different methods and study
designs [7,8]. Among these, colorectal cancer (CRC)
is the most studied cancer. The unexpected finding
that species of Fusobacterium, particularly the oral
species Fusobacterium nucleatum, are very prevalent
(about 30%) in CRC cases suggested an association
between the oral microbiota in the colon and CRC
[8]. Research on the relationships between oral bac
teria and pancreatic cancer risk stems from a number
of observational studies that have reported a higher
risk of pancreatic cancer among individuals with
periodontitis, when compared to those without peri
odontitis [9–12]. A number of studies have examined
the association of the oral microbiome with
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pancreatic cancer risk [13–16], but results were
inconsistent partially due to differences in methods
and study designs. Although one recent study found
suggestive evidence that oral dysbiosis is a causative
effect of early pancreatic cancer [13], more prospec
tive studies are needed to replicate and confirm their
findings. Defining oral microbial profiles as noninvasive biomarkers for pancreatic cancer could help
screening of high-risk populations. However, no
human study to date has correlated microbiome in
the oral cavity with the microbiome in pancreatic
tissue of the same patients.
In an effort to address the specific question of
whether the pancreas has its own microbiome, we
recruited subjects with planned foregut surgery to
obtain pancreatic tissue samples for 16S rRNA gene
microbiome analysis. The characteristics of the over
all bacterial microbiome in pancreatic and normal
surrounding tissue samples have been reported else
where [17]. Briefly, we reported that bacterial taxa
known to inhabit the oral cavity, including several
putative periodontal pathogens, were common in the
pancreas microbiome. Moreover, bacterial DNA pro
files in the pancreas were similar to those in the
duodenum tissue of the same subjects, regardless of
disease state, suggesting that bacteria may dissemi
nate from the gut into the pancreas [17]. Since oral
samples were also collected from these patients, the
present study provides a unique opportunity to
examine the oral microbiome profiles (at multiple
oral cavity sites) and their correlations with the
microbiome in pancreatic tissue and intestinal tissue
or surfaces. Additionally, we aimed to characterize
and compare the microbial communities at different
oral sites among these patients with pancreatic cancer
and other gastrointestinal diseases. Bacterial coabundance networks were also plotted to visualize
the overall community at different sampling sites.

Methods
Sampling, DNA extraction, and 16S rRNA gene
amplicon sequencing
Based on sample-availability, in the present study
subjects who underwent surgery for pancreatic dis
eases or diseases of the foregut, at the Rhode Island
Hospital between 2014 and 2016 and contributed
pancreatic tissue (pancreatic duct, normal or tumor
pancreas) or intestinal (duodenum tissue, jejunum
swab, bile duct swab) sample was analyzed. Details
of the study population and sample collection, DNA
extraction, and sequencing procedures have been
described in our previous publication [17] and in
Supplemental Material 1. Briefly, data on participants’
demographics and behavioral factors were collected
using a self-administered questionnaire, and

pancreatic tissue samples and gastrointestinal swabs
were collected during surgery using DNA-free foren
sic sterile swabs whenever possible to reduce contam
ination. Oral swabs were collected from participants
prior to surgery using sterile cytology brushes which
were immediately placed in tubes containing 700 μl
RNA later solution after collection. Saliva was col
lected using saliva kits (OMNIgene OM-501, DNA
Genotek) and processed as per manufacturers’
instructions. All samples were de-identified and
stored at −80°C until processing for DNA extraction.
Hypervariable regions of the 16S rRNA gene were
sequenced using primers targeting the V3-V4 as
paired-end reads on an Illumina platform. Subjects
contributing only stomach swab, ileum swab, and
pancreatic swab samples were excluded from the pre
sent analyses due to the small number of samples
available.
Sequence quality checking and denoising were
performed using the DADA2 Illumina sequence
denoising process [18]. Human-associated DNA con
taminants were screened out using Bowtie2 [19].
Taxonomic classification, alignment, and phyloge
netic tree building were completed using the
Quantitative Insights Into Microbial Ecology version
2 (QIIME2) [20,21]. The sequences of each sample
were rarefied to 1200 to even the difference in
sequencing depth across both oral and intestinal sam
ples for further analysis. The choice of 1200 as sam
pling depth was guided by reviewing an alpha
rarefaction curve that tested various depths ranging
between 500 and 5,000 (Figure in the Supplemental
Material 1).
Ethics approval and consent to participate
The study was approved by Lifespan’s Research
Protection Office for recruitment at RIH, as well as
the Institutional Review Boards for Human Subjects
Research at Brown University, Tufts University, and
the Forsyth Institute. A written informed consent was
obtained from all subjects. All methods carried out
were in accordance with Helsinki Declaration as
revised in 2013.
Assigning taxonomic annotation
To predict the taxonomic groups that are present in
each sample, the QIIME2 plugin (q2-featureclassifier) was used to train naïve Bayes classifiers
using multiple databases as a different set of reference
sequences. These were the Human Oral Microbiome
Database (HOMD) (version 15.1), the Silva (release
132), and the Greengenes (13_8 revision) 99% OTUs
(Operational taxonomic units) 16S rRNA gene data
bases, all trimmed to contain the V3-V4 hypervari
able region. HOMD identification was chosen as the
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default taxonomy. Whenever HOMD, Silva, and
Greengenes yielded different taxonomic results at
the species level, taxonomic information from all
datasets were kept and reported.
Statistical analyses
Analyses were carried out in QIIME2 (https://qiime2.
org), in R [22], and in Python. All analyses were
conducted using ASV as the unit of observation in
order to accurately capture bacterial strain-level
variations.
Alpha and beta diversity
For the calculation of alpha and beta-diversity mea
sures of the oral microbiome, a phylogenetic tree was
first created in order to generate phylogenetic diversity
measures such as Faith’s Phylogenetic Diversity,
unweighted and weighted UniFrac distances [23,24].
Creating a phylogenetic tree requires multiple sequence
alignment, masking, tree building, and rooting. The
masking step removes alignment positions that do
not contain enough conservation to provide meaning
ful information (default 40%). Next, the evenness and
diversity of oral microbiota in each sample was assessed
to examine the variation in the microbial profile across
different oral sampling sites. Pielou’s Evenness test and
Faith’s Phylogenetic Diversity test were calculated
using the QIIME2 diversity analyses (q2-diversity) plu
gin [25]. Computed distances were then used to gen
erate principal coordinate analysis (PCoA) plots to
visualize the arrangement of the samples in the ordina
tion space. PERMANOVA tests [26] were conducted to
compare beta-diversity measures between sampling
sites. A false discovery rate (FDR) adjusted p-value
(or q-value) less than 0.05 was considered the signifi
cant difference in beta-diversity measures between oral
sites.
Identifying shared ASVs
Descriptive analyses were performed to identify
shared ASVs between sites. Rarefied features with
a relative abundance less than or equal to 0.01
(≤1%) were set to zero. Shared ASVs between any
one of the oral sites (tongue, buccal mucosa, supra
gingival, or saliva) and any pancreatic tissue or intest
inal sites (duodenum tissue, jejunum swab, bile duct
swab) for each subject were identified. A heatmap of
the ASVs that were shared by one or more subjects
was generated in R using the packages intersect and
ggplot2.
Concordance and Pairwise Stratified Association
Associations of ASVs between oral and pancreatic
tissues or intestinal site samples were investigated
using two different types of statistical tests that
account for pairing and within-subject correlation.
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For both tests, rarefied features with a relative abun
dance less than or equal to 0.01 (≤1%) were set to
zero (i.e., set to absence), and only ASVs for which
less than 95% of the samples exhibited a relative
abundance of zero were tested.
The first test (Kappa) evaluated general concor
dance in the presence or absence of a given ASV in
each subject. Specifically, for each subject, samples
were divided into two groups: 1) oral samples,
and 2) pancreatic tissue or intestinal site samples.
The target ASV was denoted as present in a group
if at least one of the samples had a relative abundance
value larger than zero or denoted as absent if all
relative abundance values in the group were zero.
This reformatted data thus resulted in two values
for each subject: (1) whether or not the target ASV
was present in any of the oral samples from 4 oral
sampling sites and (2) whether or not the target ASV
was present in any of the pancreatic tissue or intest
inal sites for that subject. Based on these values,
Cohen’s Kappa concordance statistic was computed
[27] utilizing the R package ‘irr’, and a one-sided test
based on Kappa’s large sample standard deviation
was conducted to examine whether there is
a significant agreement in presence or absence
between oral and pancreatic tissues or intestinal site
samples for a given ASV.
Additionally, a test for Pairwise Stratified
Association (PASTA) was performed to identify
those ASVs (when present) which exhibit consistent
patterns in relative abundance between oral and pan
creatic tissues or intestinal site samples, after adjust
ing for disease status (represented by ICD10 codes)
and within-subject correlations. PASTA test was
based on a Bayesian regression model to obtain
Markov–Chain Monte Carlo estimates of abundance
among strata, to calculate a correlation statistic, and
to conduct a formal test based on its posterior dis
tribution. Samples were categorized by using four
ICD10 codes ‘C24.*’, ‘C25.*’, ‘K86.2’ and ‘other’
(encodes other gastrointestinal conditions) or by
three ICD10 codes ‘C24.*’, ‘C25.*’ and ‘other’
(includes K86.2 and other gastrointestinal conditions)
to focus on neoplasms versus other conditions (Table
1). In contrast to tests based on Kappa statistics
(which tests the concordance in presence or absence
of a given ASV between groups), PASTA tests exam
ine whether the differences in mean relative abun
dance across groups (e.g., disease status) are
preserved between body sites (e.g., oral versus pan
creatic or intestinal sites). An ASV was defined to
exhibit a consistent PASTA pattern, if either one of
the three possible quantities was associated between
oral and pancreatic tissues or intestinal site samples:
(1) The probability of absence (p), which denotes the
probability of observing a relative abundance of zero,
(2) The non-zero mean relative abundance (ω), which
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Table 1. Characteristics of subjects analyzed (n = 52).
Characteristic
Age (years)
Body mass index (kg/m2)
Sex
Male
Female
Race
Caucasian
Black
Asian
Smoking status
Ever smoker
Nonsmoker
Missing
Chemotherapy
Never
Prior to past 6 months
In past 6 months
Missing
ICD-10 codes
C24.0 (extrahepatic cholangiocarcinoma)
C25.0 – C25.9, C24.1 (pancreatic cancer and
periampullary cancer)
K86.0 – K86.3 (other pancreatic conditions)
Other gastrointestinal conditions
Oral health
Periodontal disease
Gum disease
Missing

Mean (SD)
64.1 (12.5)
26.3 (4.9),
n = 51
n (%)
24 (46)
28 (54)
49 (94)
1 (2)
2 (4)
32 (61.5)
19 (36.5)
1 (2)
37 (71.2)
5 (9.6)
6 (11.5)
4 (7.7)
3 (5.8)
29 (55.8)
15 (28.8)
5 (9.6)
4 (7.69) a
5 (9.62) a
12 (23.1)

SD = standard deviation. a 30 subjects with no periodontal or gum
disease; 1
subject had both periodontal disease and gum disease.

Ward clustering tree, permutational MANOVA
(9999 permutations, p < 0.001) was used to sequen
tially test whether any two branches of the tree were
significantly different [30]. ASVs within the same coabundance group increased or decreased in abun
dance together.
ASV co-abundance network
Bacterial co-abundance networks illustrate how
groups of ASVs occupy different niches of the micro
bial ecosystem. The co-abundance networks were
visualized as force-directed network plots using
Python package NetworkX (version 2.2) with the
spring layout of the Fruchterman-Reingold algorithm
(k = 0.15) [31] for buccal, saliva, duodenum, and
pancreatic tumor samples. Only ASVs with an abso
lute SparCC correlation value greater than 0.1 and
a p-value less than 0.05 were plotted using forcedirected algorithms [32]. Further details regarding
methods used to visualize ASV co-abundance net
works at different sampling sites are described in
Supplemental Material 2.

Results
Population and sample characteristics

denotes mean relative abundance among those sam
ples in which ASV is present; and (3) The mean
relative abundance across all samples (μ). Further
information about the data model, approach, and
performance of the PASTA test has been published
in detail [28] and briefly summarized in
Supplemental Material 2.
Both Kappa and PASTA analyses were repeated by
selecting only saliva samples at the oral site because
all studies examining the association of the oral
microbiome with pancreatic cancer risk [13–16] col
lected saliva samples.
ASV co-abundance groups
Microbial co-abundance analyses were conducted to
elucidate the distinct strain-level cluster patterns
among microbiome members. ASVs shared by more
than 10% of the buccal, saliva, duodenum, and pan
creatic tumor samples were considered prevalent
ASVs. Correlations between these prevalent ASVs
within each sampling site were calculated using the
SparCC
method
(Sparse
Correlations
for
Compositional data) [29]. The statistical significance
of these correlation coefficients was assessed using
a bootstrap procedure and then converted into
a correlation distance matrix. Next, the Ward cluster
ing algorithm, a top-down clustering approach, was
used to cluster ASVs within each sampling site into
co-abundance groups. Starting from the top of the

The present analysis included 52 subjects (Table 1). These
subjects were between 31 and 86 years old, and contributed
a total 316 sample (52 tongue swab, 46 buccal swab, 35
supragingival swab, 48 saliva samples, 22 duodenum tissue,
34 jejunum swab, and 19 bile duct swab samples, as well as
21 pancreatic ducts, 6 normal pancreatic tissues and 33
pancreatic tumor samples). Based on the pathology records,
ICD10 codes were assigned to each subject: 24 (46%) sub
jects had pancreatic cancer, 8 (15%) subjects had periampul
lary adenocarcinoma and 4 (8%) subjects had extrahepatic
cholangiocarcinoma, 11 (21%) subjects had other pancreatic
conditions, and the remaining 5 (10%) had other gastro
intestinal conditions. Sixty-two percent of these subjects were
ever smokers and 87% received antibiotic days prior to
surgery (after providing oral specimens). Five (10%) subjects
had periodontal or gum disease.
A total of 4077 unique Amplicon Sequence
Variants (ASVs) were identified across oral samples,
and 4304 ASVs were identified across pancreatic tis
sue or intestinal tissue and swab samples via DADA2.
ASVs are also referred to as ‘features’ in QIIME2
processing and can be roughly understood as unique
identifiers reaching up to the levels of bacterial strains
or a group of highly similar strains.
Microbiome communities at different sites
Based on the Shannon index (alpha-diversity mea
sure), saliva and tongue samples were more diverse
(median Shannon index >4) than buccal and
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Figure 1. Alpha- and beta-diversity of oral microbiome among patients with pancreatic cancer and other gastrointestinal
disease. Legends: Comparative alpha diversity (a. Shannon Index) and beta diversity (b. Bray–Curtis PCoA plot) analyses of
bacterial communities in buccal, saliva, gum, and tongue sites.

supragingival samples (Figure 1(a)). The coordination
of the Bray-Curtis PCoA plot (beta-diversity mea
sure) also revealed two clustering groups.
Specifically, bacterial communities from tongue and
saliva samples clustered together, while those from
buccal and supragingival samples formed another
cluster (Figure 1(b)). Bacterial communities in pan
creatic tissue and intestinal tissue or surfaces in this
population have been previously described [17].
Briefly, alpha and beta-diversity analyses did not
show any visually apparent clustering by sites (i.e.,
duodenum tissue, jejunum swab, bile duct swab, pan
creatic duct, and pancreatic tissue samples). However,
there were clear separations between oral bacterial
communities and bacterial communities from duode
num tissue, bile duct swab, pancreatic duct, and

pancreatic tissue samples; only bacterial communities
from jejunum swabs clustered with oral bacterial
communities (Figure 2)
PERMANOVA tests indicated that all samples
were significantly different from each other, except
those bacterial communities from buccal samples
were not different from supragingival samples
(q = 0.14) or saliva samples (q = 0.09), and the
pancreatic duct samples were not different from pan
creatic tumor samples (q = 0.28). (S1 Table)
Shared ASVs and taxonomy
A total of 73 ASVs were common between oral (any
site) and intestinal or pancreatic samples in at least
one subject (Figure 3; S2 Table). Taxonomic

6

M. CHUNG ET AL.

Figure 2. Bray–Curtis dissimilarity index plot across all sampling sites. Legends: Bray–Curtis PCoA plot showing the relatedness
of microbial communities among the 52 subjects across all sampling sites (i.e., duodenum, jejunum swab, bile duct swab,
normal pancreas, pancreas tumor, pancreatic duct, buccal saliva, gum, and tongue sites).

annotations of these shared ASV indicate that
Streptococcus, Veillonella, Prevotella, Fusobacterium,
Gemella, Haemophilus, and Rothia are the top seven
frequently shared genera (in descending order)
between oral and gut or pancreatic samples. The top
seven most frequently shared species include
Veillonella parvula, Streptococcus parasanguinis clade
411, Fusobacterium nucleatum subsp. vincentii,
Gemella morbillorum, Haemophilus parainfluenzae,
Prevotella veroralis, and Rothia aeria.

Concordance (Kappa) and Pairwise Stratified
Association (PASTA) between oral and pancreatic
tissue or intestinal samples
For both Kappa and PASTA tests, a total of 50 ASVs for
which less than 95% of the samples exhibited a relative
abundance of zero were tested. Based on the Kappa
statistics, four ASVs showed significant concordance
with regards to the probability of presence or absence
between any oral sample and pancreatic tissue or intest
inal samples after adjusting for multiple testing. The
taxonomy of these ASVs (same assigned taxa in all
reference databases unless otherwise noted) are:
Fusobacterium nucleatum subsp. vincentii, Rothia muci
laginosa (GG), Gemella morbillorum, and Rothia aeria
(HOMD)/mucilaginosa (GG). However, the estimated
probability to be present in both oral and pancreatic
tissue or intestinal samples were low (ranging from 3.8%
to 17%) for these four ASVs (Table 2). When analyzing

only saliva samples, total of seven ASVs showed signifi
cant concordance between saliva and pancreatic tissue
or intestinal samples, including F. nucleatum subsp.
vincentii (two ASVs), Rothia mucilaginosa (GG), and
Gemella morbillorum, Saccharibacteria_(TM7)_[G-1]
bacterium_HMT_352, Oribacterium parvum, genus
Streptococcus, and genus Fusobacterium. The estimated
probability to be present in both saliva and pancreatic
tissue or intestinal samples ranged widely from 2.1% to
56% for these seven ASVs (Table 3).
The PASTA test identified two ASVs (ASV13 and
ASV21), Gemella morbillorum and genus Streptococcus,
that showed consistent presence or absence patterns
between oral and intestinal or pancreatic samples,
after adjusting for within-subject correlation and dis
ease status. Detailed analyses are reported in the
Supplemental Material 3. The ASVs corresponding to
Gemella morbillorum (ASV13) and Fusobacterium
nucleatum subsp. vincentii (ASV28) showed marginally
significant associations with respect to p only when
only saliva samples were used to compare to pancreatic
tissue or intestinal samples.
Patterns of co-abundance between ASVs per body
site
A co-abundance network diagram and clustering tree
were graphed for the prevalent ASVs in the saliva (S1
Figure, panel a and b), buccal (S2 Figure, panel a and
b), duodenum (S3 Figure, panel a and b), jejunum (S4
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Figure 3. Shared ASVs (number of subjects) and Relative Abundance by Sampling Sites. Legends: On the left panel of the
heatmap, each ASV is labeled with an ASV ID and the number of subjects who have the ASV present in both their oral and
intestinal and pancreatic samples. Taxonomic annotations of these shared ASV are also provided on the right panel of the
heatmap.

Figure, panel a and b), and pancreatic tumor samples
(S5 Figure, panel a and b), respectively.
The Ward clustering algorithm identified six and
five co-abundance clusters in saliva and buccal
samples, respectively (S1 and S2 Figures). In buccal
samples (S2 Figure), the cluster dominated by
Veillonella parvula (Red and Green) was inversely
correlated with the co-abundance cluster that
mostly contained Fusobacterium nucleatum subsp.
vincentii,
Haemophilus
parainfluenzae,
and
Capnocytophaga gingivalis (Orange). In saliva sam
ples (S1 Figure panel b), the same Capnocytophaga

gingivalis ASV, which was also in buccal samples,
was clustered in a co-abundance group with many
Fusobacterium nucleatum subsp. vincentii and
Streptococcus ASVs (Grey). Moreover, the coabundance
cluster
that
contained
only
Fusobacterium, Neisseria, and Haemophilus parain
fluenzae (Green) was more positively correlated
with a cluster dominated by Haemophilus ASVs
and Streptococcus ASVs (Yellow), and more inver
sely correlated with a cluster of Veillonella parvula
ASVs and Prevotella veroralis ASVs (Red). The five
ASVs identified by the PASTA tests belonged to the
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Table 2. Four ASVs that showed significant agreement* with regards to the probabilities of presence or absence (Kappa
statistics) between any oral site and any pancreatic tissue or intestinal samples.
ASV IDb
ASV28
ASV23
ASV13
ASV06

Kappa (SD)
0.321 (0.102)
0.397 (0.125)
0.353 (0.133)
0.316 (0.118)

q-value
0.020
0.020
0.048
0.048

Agree obs
0.865
0.865
0.788
0.673

Prop.pp
0.038
0.058
0.096
0.173

Prop.pa
0.135
0.115
0.154
0.288

Prop.ap
0.000
0.019
0.058
0.038

Prop.aa
0.827
0.808
0.692
0.500

Genusa
Fusobacterium
Rothia
Gemella
Rothia

Species (HOMD)a
nucleatum subsp. vincentii
mucilaginosa (GG)
morbillorum
aeria/mucilaginosa GG)

Agree obs = observed agreement; ASV = Amplicon Sequence Variants; SD = standard deviation; q-value = p-value adjusted for multiple testing via the
false discovery rate method; Prop. pp = probability of an ASV to be present in both oral and any pancreatic tissue or intestinal samples; Prop.
pa = probability of an ASV to be present in oral samples but absent in pancreatic or intestinal samples; Prop. ap = probability of an ASV to be absent
in oral samples but present in pancreatic or intestinal samples; Prop. aa = probability of an ASV to be absent in both oral and any pancreatic tissue or
intestinal samples.
*Significant agreement/concordance can be reached if probability of an ASV to be present in both oral and any pancreatic tissue or intestinal samples
(Prop. pp) or probability of an ASV to be absent in both oral and any pancreatic tissue or intestinal sample (Prop. aa) is high.
a
TAXONOMIC annotations of the ASVs are from HOMD database unless otherwise noted. GG = green gene database.
b
ASV ID used in Figure 1 left panel.

Table 3. Seven ASVs that showed significant agreement* with regards to the probabilities of presence or absence (Kappa
statistics) between saliva and any pancreatic tissue or intestinal samples.
ASV IDb
ASV28
ASV23
ASV20
ASV27
ASV01
ASV47
ASV17

Kappa (SD)
0.406 (0.116)
0.492 (0.137)
0.431 (0.142)
0.357 (0.111)
0.344 (0.119)
0.309 (0.104)
0.284 (0.101)

q-value
0.004
0.004
0.013
0.009
0.016
0.014
0.017

Agree obs
0.896
0.896
0.875
0.875
0.708
0.917
0.729

Prop.pp
0.042
0.063
0.063
0.042
0.563
0.021
0.083

Prop.pa
0.104
0.083
0.083
0.125
0.271
0.000
0.271

Prop.ap
0.000
0.021
0.042
0.000
0.021
0.083
0.000

Prop.aa
0.854
0.833
0.813
0.833
0.146
0.896
0.646

Genusa
Fusobacterium
Rothia
Saccharibacteria_(TM7)_[G-1]
Oribacterium
Streptococcus
Fusobacterium
Fusobacterium

Species (HOMD)a
nucleatum subsp. vincentii
mucilaginosa (GG)
bacterium_HMT_352
parvum
nucleatum subsp. vincentii

Agree obs = observed agreement; ASV = Amplicon Sequence Variants; SD = standard deviation; q-value = p-value adjusted for multiple testing via the
false discovery rate method; Prop. pp = probability of an ASV to be present in both oral and any pancreatic tissue or intestinal samples; Prop.
pa = probability of an ASV to be present in oral samples but absent in pancreatic or intestinal samples; Prop. ap = probability of an ASV to be absent
in oral samples but present in pancreatic or intestinal samples; Prop. aa = probability of an ASV to be absent in both oral and any pancreatic tissue or
intestinal samples.
*Significant agreement/concordance can be reached if probability of an ASV to be present in both oral and any pancreatic tissue or intestinal samples
(Prop. pp), or probability of an ASV to be absent in both oral and any pancreatic tissue or intestinal sample (Prop. aa) is high.
a
TAXONOMIC annotations of the ASVs are from HOMD database unless otherwise noted. GG = green gene database.
b
SV ID used in Figure 1 left panel.

grey cluster (ASV28, ASV21, ASV13, and ASV19)
and the green cluster (ASV67) in buccal samples.
They belonged to the yellow cluster (ASV21 and
ASV19), pink cluster (ASV 13 and ASV 67), and
grey cluster (ASV28) in saliva samples.
There were 3, 8, and 4 co-abundance clusters in
the duodenum tissue, jejunum swab, and pancreatic
tumor tissue samples, respectively (S3, S4, and S5
Figures). All five ASVs identified by the PASTA
tests were shown in the jejunum swab clusters –
three ASVs (ASV13, ASV28, ASV67) belonged to
the purple cluster, one (ASV19) belonged to the yel
low cluster, and one (ASV21) belonged to the pink
cluster. One duodenum cluster was dominated by
Fusobacterium nucleatum subsp. vincentii ASVs and
Klebsiella pneumoniae ASVs (Red), and was inversely
correlated to a cluster (Green) that contained
Ralstonia,
Bacteroides,
Lachnospiraceae,
Saccharibacteria, Brevundimonas, and Sphingomonas
ASVs. In the pancreatic tumor samples, one cluster
was dominated by Fusobacterium nucleatum subsp.
vincentii, Klebsiella pneumoniae, Campylobacter rec
tus, Dialister pneumosintes, Prevotella nigrescens, and
Parvimonas micra ASVs (Red), which contains bac
teria that were identified as ‘the orange complex’ –

the transitional population between health and severe
periodontal disease [33]. Only two (ASV13 and
ASV67) of the five ASVs identified by the PASTA
tests were shown in the clusters of ASVs in duode
num samples. Both (Gemella morbillorum and
Veillonella parvula) belonged to the grey cluster.
Two ASVs (ASV13: Gemella morbillorum and
ASV67: Veillonella| arvula) consistently belonged to
the same cluster in saliva, duodenum tissue, and
jejunum swab samples. None of the five ASVs were
plotted in pancreatic tumor samples’ ASV clusters
(due to low or insignificant correlations with other
ASVs) although two (ASV13 and ASV28) were pre
sent in the pancreatic tumor samples (S1 Table).

Discussions
To our knowledge, this is the first study to date to
characterize oral bacterial microbiome communities
at four oral sites (tongue, buccal, supragingival, and
saliva) and examined their correlations with the
microbiome in the pancreatic tissue or intestinal
samples using several complementary analyses. Due
to a small number of pancreatic tissue and intestinal
samples, our analyses combined all available samples
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to increase statistical power. In this study, we identi
fied many ASVs that were shared between oral and
pancreatic or intestinal samples among patients with
pancreatic cancer and other gastrointestinal diseases,
even though pancreatic and intestinal samples had
a much lower number and abundance of ASVs com
pared to oral samples. We also identified a number of
bacteria that were correlated in oral samples and
pancreatic tissue samples and may have relevance in
the underlying disease.
Our results expand the original finding of the
Human Microbiome Project of oral biogeography in
healthy subjects [34]. When comparing oral (all sam
pling site combined) to intestinal or pancreatic sam
ples, four ASVs showed significant concordance
(Kappa statistics) and five ASVs exhibited significant
or marginally significant associations (PASTA) with
regards to the probabilities of absence or presence.
We do not have sufficient statistical power to exam
ine which oral site might be the ‘best’ oral sampling
site; however, we did compare saliva to intestinal sites
as saliva is often the collection of choice in observa
tional cohort studies. Overall, the concordance of the
ASVs (when present) between any oral site and pan
creatic or intestinal sites was low, suggesting that
while oral bacteria are likely migrating to the gastro
intestinal sites, oral samples may now be used to
measure the bacteria in the pancreas directly. When
analyzing overall microbial communities at different
sampling sites, the microbial co-abundance analyses
illustrate the distinct strain-level cluster patterns
among microbiome members in buccal, saliva, duo
denum, and pancreatic tumor samples. Our results
provide initial insights for future studies to begin to
uncover and define the co-abundance of specific oral
microbiome communities and to explore their poten
tial roles in monitoring the process of pancreatic
carcinogenesis or disease progressions.
Emerging research has focussed on profiling oral
microbiome as potential biomarkers for disease phe
notypes in epidemiological studies [35] because they
are noninvasive, and oral microbiome profiles have
shown relative intraindividual stability over time and
clear interindividual differences [36,37]. Although
many observational studies have shown that specific
oral microbiota in oral cavities and in the fecal sam
ples are associated with oral, head and neck, lung,
colorectal, and pancreatic cancer risks [7,8,38], data
on the associations between oral and tissue micro
biome profiles are very limited. To our knowledge,
there is only one prior study that examined the
microbial profiles that were shared between the oral
cavity and tissue samples [39]. Their analyses have
focussed on 17 OTUs that were detected in 37% of
both tissue samples (CRC and polyp) and oral swabs,
and identified two tumor-associated bacterial coabundance clusters. Specifically, one cluster is
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comprised of oral pathogens previously linked with
late colonization of oral biofilms and with human
diseases including CRC (e.g., Fusobacterium nuclea
tum, Parvimonas micra, Peptostreptococcus stomatis,
and Dialister pneumosintes), and the other cluster is
comprised of dominant bacteria in early dental bio
film formation including genera Actinomyces,
Haemophilus, Rothia, Streptococcus, and Veilonella
[39]. A letter to the editor reported that
Fusobacterium nucleatum was detected in 8 (57.1%)
of 14 CRC patients’ tumor and saliva samples, and
identical strains were found in 75% of the tumor and
saliva samples suggesting that F. nucleatum in color
ectal tumor originates in the oral cavity [40]. In the
present study, we identified 73 ASVs shared between
oral and intestinal or pancreatic (Figure 2; S1 Table).
In our study, only F. nucleatum was identified from
the 1st cluster of the work of Flemmer et al. [39],
however, all except Actinomyces was found from
the second cluster. We found that F. nucleatum was
among the top three most frequently shared species
based on the taxonomic annotations of the shared
ASVs between oral and intestinal or pancreatic
samples.
Our co-abundance analyses identified multiple
clusters of ASVs in buccal, saliva, duodenum, jeju
num swab, and pancreatic tumor samples. In buccal
and saliva samples, Capnocytophaga gingivalis ASV
was consistently found in the same co-abundance
group with Fusobacterium nucleatum subsp. vincen
tii ASVs. Of the four clusters of ASVs in pancreatic
tumor samples, one cluster with the largest number
of ASVs comprised mostly the dominant bacteria in
early dental biofilm formation or the genera also
associated with relatively healthy tooth pockets
[33], and the other three clusters each contain bac
terial species that are associated with cancer risks
such as Gemella morbillorum and Fusobacterium
nucleatum subsp. vincentii, as well as species that
are associated with periodontal disease or infections
such as Prevotella nigrescens, Campylobacter rectus,
and Klebsiella pneumoniae [41,42]. A recent study
investigating the microbiome of intraductal papil
lary mucous neoplasms, lesions which can progress
to pancreatic cancer, also demonstrated that the oral
pathogen F. nucleatum co-occurred with 10 other
species, including Serratia marcescens, Parvimonas
micra, Prevotella melaninogenica, Haemophilus
parahaemolyticus,
Streptococcus
anginosus,
Bergeyella sp. HMT322, Kluyvera ascorbata,
Eikenella corrodens, Campylobacter concisus, and
Campylobacter showae, many of which are known
oral species [43].
After adjusting for disease status, our PASTA ana
lyses identified two specific bacterial species (Gemella
morbillorum and Fusobacterium nucleatum subsp.
vincentii) that showed consistent presence or absence
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patterns between oral and intestinal or pancreatic
samples, which warrant further investigations on
their associations to the pancreatic cancer risk or
progression. A few studies had shown associations
between these bacterial species and CRC risk.
A large retrospective study found that the risk of
CRC was significantly increased in patients with cul
ture-confirmed bacteremia (presence of bacteria in
the blood) from Gemella morbillorum, previously
known as Streptococcus morbillorum (HR = 15.2;
95% CI = 1.54–150), and from Fusobacterium nucle
atum (HR = 6.89; 95% CI = 1.70–27.9) [44]. A casecontrol study in a cohort of individuals undergoing
screening colonoscopy found that both Gemella mor
billorum and F. nucleatum (part of 21 species-level
OTUs) were enriched in fecal samples from CRC
patients compared to controls [38]. This study also
showed strong co-abundance relationships between
Parvimonas micra, F. nucleatum, and Solobacterium
moorei. Another study analyzed the association of
Fusobacterium species in pancreatic tumor with
patient prognosis and showed significantly higher
mortality (poorer prognosis) among pancreatic can
cer patients with Fusobacterium species-positive
tumors than those with Fusobacterium speciesnegative
tumors
(HR
=
2.16;
95%
CI = 1.12–3.91) [45].
A growing number of studies have investigated the
relationship between the oral microbiome and pan
creatic cancer risk using different methods and study
designs, but the results have been inconsistent, and
most studies had small sample sizes [13–16]. The
largest study to date of the oral microbiome and
pancreatic cancer capitalized on data collected on
patients in two large prospective cohort studies to
conduct a nested case-control study [13]. The results
showed that presence (vs absence) of P. gingivalis and
Aggregatibacter actinomycetemcomitans in saliva col
lected prior to cancer diagnosis was associated with
a 60% and 120% increase in the risk of pancreatic
cancer, respectively. In contrast, the presence (vs
absence) of Leptotrichia in saliva was associated
with a 13% decreased risk of pancreatic cancer [13].
None of the bacterial species or genus that were
different in saliva samples comparing pancreatic can
cer patients to healthy controls (in prior studies)
showed significant concordance or PASTA associa
tions between saliva and pancreatic tissue or intest
inal samples in our analyses. The most recently
published study evaluated the characteristics of the
oral microbiota in patients with pancreatic ductal
adenocarcinoma (PDAC), intraductal papillary muci
nous neoplasms (IPMNs), and healthy controls [15].
This case-control study found no differences between
patients with PDAC and healthy controls or between
patients with PDAC and those with IPMNs, on mea
sures of alpha diversity of the oral microbiota. PDAC

patients had higher levels of Firmicutes and several
related taxa (Bacilli, Lactobacillales, Streptococcaceae,
Streptococcus, Streptococcus thermophilus), although,
after adjustment for multiple testing, results remained
significant at the phylum level only. In our data, an
ASV corresponding to genus Streptococcus was the
only ASV showing a high probability (56%) to be
present in both saliva and pancreatic tissue or intest
inal samples.
Our study has several strengths. We used ASVs
from Illumina-scale amplicon data in all analyses
without imposing the arbitrary dissimilarity thresh
olds that define molecular OTUs. ASVs capture all
biological variation present in the data, and ASVs are
consistently labeled with intrinsic biological meaning
as a DNA sequence [46]. By analyzing ASVs, our
analyses overcame the main challenge of 16S rRNA
sequence taxonomic classification, that is selecting
appropriate marker genes that contain sufficient het
erogeneity in order to ensure accurate differentiation
of target species [47]. Additionally, our study results
can be reliably reproduced and validated in future
studies. However, our study also had some limita
tions; our sample size was small and PASTA tests
were likely underpowered. About 20% of our study
population received chemotherapy and 87% received
antibiotic days prior to surgery (after providing oral
specimens), which may confound our findings.
Moreover, we did not have samples from healthy
controls and could not compare our findings with
prior studies due to differences in methods.

Conclusions
Taken together, the results of the present study sug
gest that members of oral, intestinal, and pancreatic
bacterial microbiomes overlap but exhibit distinct coabundance patterns in patients with pancreatic cancer
and other gastrointestinal diseases. Our findings pro
vide critical insights on microbial communities and
species that are common in the oral cavity, intestinal,
and pancreatic tissue samples among pancreatic can
cer patients and other gastrointestinal diseases.
Though due to the cross-sectional study design, we
are unable to make any conclusion regarding their
roles in disease progression or whether these bacterial
species were colonizing or just passing through var
ious body sites. Our findings should be validated in
independent and adequately sized populations with
appropriate controls. Moreover, growing evidence
have shown that bacterial species may survive,
decline, and adapt as interdependent functional
groups responding to environmental changes
[30,48,49]. Future studies should aim to uncover the
co-abundance of specific microbial communities to
explore their potential roles in the etiology of
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microbiota-driven carcinogenesis in prospective and
longitudinal studies.
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